Dr. Claudia Süssmuth Dyckerhoff will not seek re-election to the Roche Board of Directors at the 2026 Annual General Meeting. She has served on the board since March 2016. Dr. Süssmuth Dyckerhoff plans to join the board of another healthcare industry company. Roche Chairman Severin Schwan thanked her for her significant contributions and dedication over the past decade. He highlighted her profound knowledge of the healthcare industry and understanding of international market dynamics, particularly in Asia. Roche, founded in 1896, is a global leader in biotechnology and in-vitro diagnostics. The company focuses on developing medicines and diagnostics to improve and save lives. Roche is committed to personalized healthcare and aims to transform healthcare delivery. Sustainability is a core principle, with a commitment to achieving net zero by 2045.